Atlantic Edge Private Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1K Hold
134
0.01% 280
2025
Q4
$32.3K Hold
134
0.01% 267
2025
Q3
$36.7K Hold
134
0.01% 239
2025
Q2
$34.6K Hold
134
0.01% 235
2025
Q1
$30K Hold
134
0.01% 237
2024
Q4
$30.6K Sell
134
-25
-16% -$6.02K 0.01% 231
2024
Q3
$38.8K Hold
159
0.01% 219
2024
Q2
$30.4K Hold
159
0.01% 225
2024
Q1
$31.5K Hold
159
0.01% 223
2023
Q4
$27.4K Buy
+159
New +$24.4K 0.01% 218

Other funds holding RMD

Atlantic Edge Private Wealth Management's RMD Position: Q1 2026 in Review

Atlantic Edge Private Wealth Management held its ResMed (RMD) position steady in Q1 2026 at 134 shares worth $30.1K. The position accounts for 0.01% of the portfolio, ranked #280.

Atlantic Edge Private Wealth Management first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $38.8K in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Atlantic Edge Private Wealth Management held 134 shares of ResMed worth $30.1K as of Q1 2026.
  • Atlantic Edge Private Wealth Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.01% of Atlantic Edge Private Wealth Management's portfolio in Q1 2026, its #280 holding.
  • Atlantic Edge Private Wealth Management first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
  • Atlantic Edge Private Wealth Management's ResMed position peaked at $38.8K in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.